Portola Capital Partners

Portola Capital Partners

Portola Capital Partners


Silicon Valley, CA

Type of Company



Private Equity & Venture Capital
Investment Services & Portfolio Management

Executives & Employees

Managing Partner

Vice President & Senior Investment Analyst

Paths to Portola Capital Partners
Potential Connections via
Relationship Science
Portola Capital Partners
Details Hidden

Cidara Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of anti-infectives for the treatment of fungal infections. Its portfolio includes CD101 IV, CD101 Topical, and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.

Details Hidden

Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Portola Capital Partners. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Portola Capital Partners's profile does not indicate a business or promotional relationship of any kind between RelSci and Portola Capital Partners.